ENLV icon

Enlivex Therapeutics
ENLV

Overview Fund Trends Analyst Outlook Journalist POV

4 hedge funds and large institutions have $1.91M invested in Enlivex Therapeutics in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

less ownership

Funds ownership: →

less funds holding

Funds holding: →

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5

Holders
4
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$159K
2
+$58.9K
3
+$8K

Top Sellers

1
-$118K
2
-$93K
3
-$65K
4
Two Sigma Investments
Two Sigma Investments
New York
-$56K
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$51K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.77M
2
$64K
3
$61K
4
$8K
5
–
6
–
7
–
8
–